Drug intelligence / Profile preview

irradiated red blood cells

Development stage
Unknown
Modality
Tissue Cells → Other Cell Types → Cell Therapies
Administration
Intravenous, Intrauterine
01

Overview

Irradiated red blood cells are a modified blood product in which standard donor red cell units are exposed to ionizing radiation (typically gamma rays or X-rays) to prevent the proliferation of viable T lymphocytes. This process is performed to prevent transfusion-associated graft-versus-host disease (TA-GVHD), a rare but often fatal complication of transfusion caused by donor lymphocytes engrafting and attacking recipient tissues. The irradiation process inactivates T lymphocytes while preserving the function and viability of the red blood cells for transfusion. Indications for use include patients at high risk for TA-GVHD, such as those receiving transfusions from relatives, hematopoietic stem cell transplant recipients, neonates undergoing intrauterine or exchange transfusions, patients with severe congenital T-cell immunodeficiency syndromes, and individuals treated with certain immunosuppressive therapies[1][2][3][5][6][7][8]. Irradiation does not affect dosing compared to non-irradiated products but shortens shelf life post-irradiation due to increased cellular damage[3][8].

Other names
irradiated RBCsirradiated packed red blood cells

Beyond the preview

Go deeper on irradiated red blood cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on irradiated red blood cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call